Jul 6, 2026 · 7 min
Big deals test biotech, chemicals and AI infrastructure
Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf Jumps
The episode connects two large acquisitions with TeraWulf’s risky shift from Bitcoin mining to AI data centers.
- 1Vertex pursues endocrinology through a reported $10 billion acquisition of Crinetics Pharmaceuticals.
- 2Solstice Advanced Materials targets specialty-chemicals scale with its $14.5 billion purchase of Element Solutions.
- 3TeraWulf’s Anthropic lease underscores both the promise and volatility of its AI data-center pivot.
Don't miss
TeraWulf’s 20-year lease with Anthropic crystallizes the company’s transformation from Bitcoin miner to AI data-center operator.
The brief
Carol Massar, Emily Graffeo and Billy Lipschultz examine three market-moving stories: major biotech and chemicals deals, followed by TeraWulf’s AI infrastructure pivot.
Vertex Pharmaceuticals’ reported $10 billion acquisition of Crinetics Pharmaceuticals reflects biotech’s push to build portfolios before patent cliffs, where investment outcomes can be unusually binary.
Solstice Advanced Materials’ $14.5 billion acquisition of Element Solutions extends the consolidation story into specialty chemicals and adds another large strategic bet.
TeraWulf’s transition from Bitcoin mining to AI data centers is anchored by a 20-year lease with Anthropic, while high short interest amplifies the stock’s volatility.
Taken together, the deals show companies buying future growth while investors weigh strategic ambition against execution risk and sharply shifting market expectations.
What was said on this episode
13 statements · 5 positive · 2 negative · 2 mixed · 4 neutral
Vertex Pharmaceuticals agreed to acquire Kinetics Pharma for $85 per share.
“Vertex Pharmaceuticals agreeing to acquire kinetics Pharma for 85 bucks a share.”
Listen at 1:07
The Vertex-Kinetics deal has approximately $10 billion equity value, or $8.8 billion net of cash.
“the driver for that total equity value, about $10 billion, 8.8 billion net of estimated cash.”
Listen at 1:25
Vertex had a $134 billion market capitalization before the deal.
“$134 billion market cap prior to this deal.”
Listen at 1:48
Pharmaceutical companies face upcoming patent cliffs.
“they're staring down patent cliffs.”
Listen at 2:16
Solstice agreed to acquire Element Solutions, whose stock fell a record 15%.
“Solstice agreeing to acquire Element Solutions Ticker Sols dropping a record 15%.”
Listen at 2:33
The Solstice-Element Solutions deal is valued at $14.5 billion.
“$14.5 billion.”
Listen at 2:50
Element Solutions shareholders receive $10 cash and half a Solstice share.
“shareholders for Element getting $10 in cash, half a share of Solstice stock.”
Listen at 2:55
TerraWulf can transition from cryptocurrency mining to data-center operations by reworking infrastructure.
“you just got to rework the functionality of your projects, rip out some of the infrastructure and all of a sudden you're no longer a crypto miner. Now you're a data center operator.”
Listen at 3:48
TerraWulf announced a 20-year Anthropic data-center lease in Kentucky.
“This does come after the company announced a 20 year lease with Anthropic for a data center in Kentucky.”
Listen at 4:04
A long-term Anthropic partnership benefits TerraWulf.
“never hurts when you're partnered with Anthropic for the long haul.”
Listen at 4:22
TerraWulf stock rose over 90% year to date and 362% over 12 months.
“It's up over 90%, up 362% on 12 month average.”
Listen at 4:29
TerraWulf's intraday rise may have reflected a short squeeze.
“short squeeze, call me crazy, some of those trading dynamics.”
Listen at 5:01
TerraWulf stock is highly volatile amid Bitcoin and AI exposure.
“Yeah. Volatility, bitcoin, AI. You're up, you're down.”
Listen at 5:08
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Vertex Pharmaceuticals
Solstice Advanced Materials
Element Solutions Inc
TeraWulf
AnthropicListen to the full episode and explore every guest, topic, and moment on PodLume.